Rhythm Pharmaceuticals Inc (RYTM) stock news · rev $189.8M
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
This RYTM news page leads with what Rhythm Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for RYTM yet. We will not pad this page with generic market recap.
Latest reported RYTM revenue for 2025-12-31 was $189.8M. Net income was -$196.5M. Revenue was up 45.8% from 2024-12-31 to 2025-12-31. RYTM currently screens at market cap $6.49B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RYTM stock page; for the tape open the quote page.
RYTM stock news FAQ
What are RYTM's latest revenue and net income?
Latest cached Rhythm Pharmaceuticals Inc (RYTM) revenue for Dec 31, 2025 was $189.8M. Net income was -$196.5M. Statements: https://lician.com/financials/rytm
How did RYTM revenue change from the prior cached period?
Cached Rhythm Pharmaceuticals Inc (RYTM) revenue was up 45.8% from $130.1M (Dec 31, 2024) to $189.8M (Dec 31, 2025). Statements: https://lician.com/financials/rytm
What is RYTM's market cap?
Rhythm Pharmaceuticals Inc (RYTM) market cap is $6.49B on the latest cached fundamentals snapshot.
What kind of company is RYTM?
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Where is RYTM stock news listed?
Cached stock news for Rhythm Pharmaceuticals Inc (RYTM) is listed at https://lician.com/news/rytm. Filings: https://lician.com/sec/rytm
Not investment advice.